Well some of it WAS twisted but the majority is what

Arclin's Strategic Move for Nomex® Expansion Looks like Arclin’s not messing around. They're throwing some serious cash down in Asturias, Spain, to ramp up production of Nomex®—a material hotter than a blacktop in July with demand surging across aerospace, electric vehicles, and defense sectors. "When we bought the Nomex® business, we committed to investing in its...

Unicycive's Rough Ride: Not Just a Bump Picture this: Your stock takes a nosedive over 39% in a day, just after a critical drug application gets slammed by the FDA—for the second time. That’s the story with Unicycive Therapeutics, Inc., ticker NASDAQ: UNC, a company that's been handing out one nail-biting moment after another to its investors. It's not just a minor...

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Surpassing Expectations with Record Metrics Well, if it isn’t another stellar quarter for S&T Bancorp (NASDAQ:STBA). The folks over in Indiana, PA, just threw down some serious numbers. The third quarter of 2026 saw net income climbing to $38.6 million, up from $36.6 million last quarter. That's a decent hike if you ask me. But what really stole the spotlight here was...

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

AI Meets Human Expertise in Clinical Decision-Making Look, in the labyrinth of healthcare, we’re seeing a revolution with AI stepping in—not to replace the doctor, but to stand alongside them like a trusty assistant. Tairex, from the halls of Tsinghua University's Institute for AI Industry Research (AIR), has thrown its hat into this ring by unveiling their...

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Nel ASA's New Leader Announced In the latest shake-up at Nel ASA (OSE: NEL), Morten Holum is getting ready to take the reins as CEO. By May 1, 2027, Holum will step into the shoes left by Håkon Volldal. And folks, this isn't your average leadership swap. Holum brings a hefty toolkit to this hydrogen powerhouse, having been part of the action across the hydrogen value...

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Understanding the Importance of Class Actions for Investors In the world of investing, class actions serve as crucial tools for holding companies accountable for their actions. Investors, particularly those who have purchased stocks during a defined time frame, like those involved with Freeport-McMoRan Inc. (NYSE: FCX), stand to benefit significantly from these legal...

Insights into ADMA Biologics and Ongoing Investigations Investors interested in ADMA Biologics, Inc. should be aware that the company is currently under investigation for potential securities fraud, prompting discussions about recovery options for those impacted. Understanding these developments can offer investors crucial insights into the company's future prospects and...

Understanding Your Rights as a Zentalis Investor Kuehn Law, a prominent shareholder litigation firm, is currently investigating the actions of the management team at Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL). The focus lies on whether certain officers and directors have acted in ways that undermine their fiduciary responsibilities. These responsibilities include...

Understanding Current Market Dynamics In a time of significant market fluctuations, risk assets are facing pressure due to a complex mix of economic indicators and investor sentiment. Recent developments in US equities have created a landscape where volatility is the norm. This analysis will delve into various market segments, focusing on key events that shape the current...

Harnessing Waste Heat to Drive Clean Energy Solutions ATS Energy, a trailblazer in renewable energy technology, is making significant strides in turning industrial waste heat into valuable electricity. This revolutionary process not only enhances energy efficiency but also contributes to a more sustainable future. The introduction of the bipartisan Waste Heat to Wattage...